Efficacy and effects on quality of life (QOL) of tamsulosin versus naftopidil in elderly men with lower urinary tract symptoms (LUTS) and overactive bladder (OAB).

Trial Profile

Efficacy and effects on quality of life (QOL) of tamsulosin versus naftopidil in elderly men with lower urinary tract symptoms (LUTS) and overactive bladder (OAB).

Not stated
Phase of Trial: Phase IV

Latest Information Update: 22 Mar 2011

At a glance

  • Drugs Naftopidil (Primary) ; Tamsulosin (Primary)
  • Indications Lower urinary tract symptoms; Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Mar 2011 Results presented at the 26th Congress of the European Association of Urology.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top